AChE and RACK1 Promote the Anti-inflammatory Properties of Fluoxetine
Overview
Neurology
Authors
Affiliations
Selective serotonin reuptake inhibitors (SSRIs) show anti-inflammatory effects, suggesting a possible interaction with both Toll-like-receptor 4 (TLR4) responses and cholinergic signaling through as yet unclear molecular mechanism(s). Our results of structural modeling support the concept that the antidepressant fluoxetine physically interacts with the TLR4-myeloid differentiation factor-2 complex at the same site as bacterial lipopolysaccharide (LPS). We also demonstrate reduced LPS-induced pro-inflammatory interleukin-6 and tumor necrosis factor alpha in human peripheral blood mononuclear cells preincubated with fluoxetine. Furthermore, we show that fluoxetine intercepts the LPS-induced decreases in intracellular acetylcholinesterase (AChE-S) and that AChE-S interacts with the nuclear factor kappa B (NFκB)-activating intracellular receptor for activated C kinase 1 (RACK1). This interaction may prevent NFκB activation by residual RACK1 and its interacting protein kinase PKCβII. Our findings attribute the anti-inflammatory properties of SSRI to surface membrane interference with leukocyte TLR4 activation accompanied by intracellular limitation of pathogen-inducible changes in AChE-S, RACK1, and PKCβII.
The roles of RACK1 in the pathogenesis of Alzheimer's disease.
He W, Shi X, Dong Z J Biomed Res. 2024; 38(2):137-148.
PMID: 38410996 PMC: 11001590. DOI: 10.7555/JBR.37.20220259.
Mojiri-Forushani H, Khajehali E, Adelipour M, Mohammadi A Mol Biol Rep. 2022; 50(3):2231-2241.
PMID: 36571654 PMC: 9791631. DOI: 10.1007/s11033-022-08219-x.
Matt S Brain Behav Immun Health. 2021; 18:100353.
PMID: 34647105 PMC: 8495104. DOI: 10.1016/j.bbih.2021.100353.
Suppression of cigarette smoke induced MMP1 expression by selective serotonin re-uptake inhibitors.
Adam G, Shiomi T, Monica G, Jarrod S, Vincent A, Becky M FASEB J. 2021; 35(7):e21519.
PMID: 34137477 PMC: 9292461. DOI: 10.1096/fj.202001966RR.
Liu E, Xia Y, Kong X, Guo M, Yu A, Zheng B Acta Pharm Sin B. 2020; 10(10):1926-1942.
PMID: 33163344 PMC: 7606108. DOI: 10.1016/j.apsb.2020.05.005.